Moderna (MRNA) has had the highest return since April 1, 2026 by a large-cap US stock, returning 313.9%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 313.9% |
10X Genomics (TXG) | 247.78% |
Dell Technologies (DELL) | 247.05% |
Twist Bioscience (TWST) | 210.62% |
Atlassian (TEAM) | 204.08% |
Corcept Therapeutics (CORT) | 198.42% |
Hewlett Packard Enterprise (HPE) | 192.81% |
Oscar Health (OSCR) | 191.93% |
Astera Labs (ALAB) | 191.44% |
Advanced Micro Devices (AMD) | 186.26% |
Okta (OKTA) | 183.85% |
Micron Technology (MU) | 183.51% |
Crowdstrike (CRWD) | 165.16% |
Marvell Technology (MRVL) | 163.95% |
Everpure (P) | 155.61% |
United Microelectronics (UMC) | 154.68% |
Humana (HUM) | 150.4% |
Palo Alto Networks (PANW) | 150.13% |
Rubrik (RBRK) | 141.61% |
Datadog (DDOG) | 138.36% |
NetApp (NTAP) | 136.04% |
Fortinet (FTNT) | 135.95% |
Snowflake (SNOW) | 134.16% |
Sandisk (SNDK) | 128.02% |
Intel (INTC) | 125.22% |
Large-cap stocks are treated as having a market cap of $10B+.